Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis (Q35870131)

10 August 2017

Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

10 August 2017

1 reference

inferred from title

hepatic encephalopathy

1 reference

1

Jasmohan S Bajaj

1 reference

10 August 2017

Steven D Pinkerton

2

1 reference

10 August 2017

Arun J Sanyal

series ordinal

3

1 reference

10 August 2017

Douglas M Heuman

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

10 August 2017

1 reference

10 August 2017

55

1 reference

10 August 2017

4

1 reference

10 August 2017

1164-1171

1 reference

Driving simulation can improve insight into impaired driving skills in cirrhosis

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Rifaximin treatment in hepatic encephalopathy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Neuropsychological characterization of hepatic encephalopathy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319334

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

11 July 2018

1 reference

Minimal hepatic encephalopathy impairs fitness to drive.

21 January 2018

1 reference

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy.

21 January 2018

1 reference

Improving the inhibitory control task to detect minimal hepatic encephalopathy.

21 January 2018

1 reference

Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).

21 January 2018

1 reference

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy

21 January 2018

1 reference

21 January 2018

Drug therapy: rifaximin

1 reference

The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis

21 January 2018

1 reference

Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

21 January 2018

1 reference

Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life.

21 January 2018

1 reference

Patients with minimal hepatic encephalopathy have poor insight into their driving skills

21 January 2018

1 reference

Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy

21 January 2018

1 reference

12 December 2020

Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

1 reference

12 December 2020

Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism

1 reference

12 December 2020

Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy

1 reference

12 December 2020

Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy

1 reference

12 December 2020

Testing for minimal hepatic encephalopathy in the United States: An AASLD survey

1 reference

12 December 2020

Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy

1 reference

12 December 2020

Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations

1 reference

12 December 2020

Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life

1 reference

12 December 2020

The demise of the pencil? New computer-assisted tests for minimal hepatic encephalopathy

1 reference

12 December 2020

Road traffic injuries: a major global public health crisis

1 reference

12 December 2020

Identifiers

DOI

10.1002/HEP.25507

1 reference

10 August 2017

1 reference

10 August 2017

1 reference